Literature DB >> 9591700

A proposal for standardizing urine collections for bone resorption markers measurement.

M Zaninotto1, D Bernardi, F Ujka, P Bonato, M Plebani.   

Abstract

Diurnal variations in the excretion of bone resorption markers were assessed in order to identify the type of urine collection which provides the most information on bone resorption rate and its relation to measuring bone dynamics in a postmenopausal population. Sixty women, ages 43-67 and without disease or treatment known to affect bone mineral density, were divided into two groups on the basis of femoral mineral density T-score: <1.5 (Group I), >1.5 (Group II). Bone formation was assessed by measuring bone alkaline phosphatase activity and osteocalcin concentration, bone resorption by urinary hydroxyproline, pyridinoline and deoxypiridinoline, N-telopeptide, galactosyl hydroxylysine, and CrossLaps. To identify the more appropriate collection times, urine samples were collected from 7 am to 3 pm; from 3 pm to 11 pm; from 11 pm to 7 am. Twenty-four hour urine collection and first morning void urine samples were also measured. The findings suggest that nocturnal collection and first morning void samples provide the most reliable data on the rate of bone degradation, possibly showing bone loss not only in osteopenic patients but also in women with a low T-score. Nocturnal and first morning samples should therefore be recommended in order to standardize sample collection, as they enable an accurate assessment of bone resorption markers and improved comparability to results from different studies, as well as a less cumbersome collection modality.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591700      PMCID: PMC6808053          DOI: 10.1002/(sici)1098-2825(1998)12:3<145::aid-jcla3>3.0.co;2-8

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  9 in total

1.  Biological variation in urinary excretion of pyridinium crosslinks: recommendations for the optimum specimen.

Authors:  M Panteghini; F Pagani
Journal:  Ann Clin Biochem       Date:  1996-01       Impact factor: 2.057

Review 2.  The role of biochemical tests in the screening and monitoring of osteoporosis.

Authors:  C P Price; P W Thompson
Journal:  Ann Clin Biochem       Date:  1995-05       Impact factor: 2.057

Review 3.  Biochemical markers of bone metabolism.

Authors:  L Risteli; J Risteli
Journal:  Ann Med       Date:  1993-08       Impact factor: 4.709

4.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

Review 5.  Osteoporosis: assessment of bone loss and remodeling.

Authors:  J A McGowan
Journal:  Aging (Milano)       Date:  1993-04

6.  Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

Authors:  B J Gertz; P Shao; D A Hanson; H Quan; S T Harris; H K Genant; C H Chesnut; D R Eyre
Journal:  J Bone Miner Res       Date:  1994-02       Impact factor: 6.741

7.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Authors:  P Garnero; W J Shih; E Gineyts; D B Karpf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Biochemical markers of bone turnover for the clinical assessment of bone metabolism.

Authors:  A K Taylor; S A Lueken; C Libanati; D J Baylink
Journal:  Rheum Dis Clin North Am       Date:  1994-08       Impact factor: 2.670

9.  Immunoassay for quantifying type I collagen degradation products in urine evaluated.

Authors:  M Bonde; P Qvist; C Fledelius; B J Riis; C Christiansen
Journal:  Clin Chem       Date:  1994-11       Impact factor: 8.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.